Spatial and functional heterogeneity of follicular helper T cells in autoimmunity.


Journal

Current opinion in immunology
ISSN: 1879-0372
Titre abrégé: Curr Opin Immunol
Pays: England
ID NLM: 8900118

Informations de publication

Date de publication:
12 2019
Historique:
received: 03 06 2019
revised: 21 06 2019
accepted: 25 06 2019
pubmed: 3 8 2019
medline: 31 7 2020
entrez: 3 8 2019
Statut: ppublish

Résumé

Follicular helper T cells provide signals that promote B cell development, proliferation, and production of affinity matured and appropriately isotype switched antibodies. In addition to their classical locations within B cell follicles and germinal centers therein, B cell helper T cells are also found in extrafollicular spaces - either in secondary lymphoid or non-lymphoid tissues. Both follicular and extrafollicular T helper cells drive autoantibody-mediated autoimmunity. Interfering with B cell help provided by T cells can ameliorate autoimmune disease in animal models and human patients. The next frontier in Tfh cell biology will be identification of Tfh cell-specific pathogenic changes in autoimmunity and exploiting them for therapeutic purposes.

Identifiants

pubmed: 31374450
pii: S0952-7915(19)30015-9
doi: 10.1016/j.coi.2019.06.005
pmc: PMC7255639
mid: NIHMS1563161
pii:
doi:

Substances chimiques

Autoantibodies 0
Biomarkers 0
Cytokines 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-9

Subventions

Organisme : NIAMS NIH HHS
ID : R01 AR074545
Pays : United States
Organisme : NIAMS NIH HHS
ID : R37 AR040072
Pays : United States

Informations de copyright

Copyright © 2019. Published by Elsevier Ltd.

Références

Nat Rev Rheumatol. 2016 Feb;12(2):102-10
pubmed: 26581343
Nat Immunol. 2015 Feb;16(2):142-52
pubmed: 25594465
J Immunol. 2012 Feb 15;188(4):1656-67
pubmed: 22231702
J Immunol. 2004 Nov 1;173(9):5361-71
pubmed: 15494482
Arthritis Rheumatol. 2015 Mar;67(3):773-84
pubmed: 25385309
Front Immunol. 2018 Apr 09;9:689
pubmed: 29686678
FASEB J. 2016 Feb;30(2):761-74
pubmed: 26499265
Immunity. 2011 Jan 28;34(1):108-21
pubmed: 21215658
PLoS One. 2013 Jun 24;8(6):e67003
pubmed: 23826184
Nat Commun. 2017 Oct 17;8(1):978
pubmed: 29042531
Proc Natl Acad Sci U S A. 2006 Jun 27;103(26):9970-5
pubmed: 16777955
J Autoimmun. 2019 Jun;100:95-104
pubmed: 30878167
Nat Rev Rheumatol. 2012 May 01;8(6):337-47
pubmed: 22549246
J Immunol. 2016 Jan 1;196(1):80-90
pubmed: 26608911
Immunity. 2014 Oct 16;41(4):529-42
pubmed: 25367570
Ann Rheum Dis. 2018 Sep;77(9):1354-1361
pubmed: 29853448
Sci Rep. 2016 May 27;6:26494
pubmed: 27231124
Science. 2009 Mar 13;323(5920):1488-92
pubmed: 19286559
Immunol Lett. 2017 Jan;181:101-108
pubmed: 27662792
J Immunol. 2007 Mar 15;178(6):3822-30
pubmed: 17339481
Clin Exp Immunol. 2013 Nov;174(2):212-20
pubmed: 23786438
Sci Transl Med. 2014 Apr 2;6(230):230ra46
pubmed: 24695686
Immunity. 2015 Oct 20;43(4):690-702
pubmed: 26410627
J Immunol. 2010 May 1;184(9):5085-93
pubmed: 20351185
J Clin Invest. 2015 Jun;125(6):2194-202
pubmed: 25938780
Science. 2006 Jun 16;312(5780):1669-72
pubmed: 16709748
Nat Commun. 2017 Jan 03;8:13957
pubmed: 28045014
J Immunol. 2017 Apr 1;198(7):2578-2588
pubmed: 28219887
Nat Immunol. 2012 May;13(5):491-8
pubmed: 22466669
Nat Rev Rheumatol. 2017 May;13(5):280-290
pubmed: 28360423
Annu Rev Immunol. 1994;12:487-520
pubmed: 8011289
N Engl J Med. 2007 Sep 6;357(10):977-86
pubmed: 17804842
Nature. 2017 Feb 1;542(7639):110-114
pubmed: 28150777
Proc Natl Acad Sci U S A. 2009 Feb 3;106(5):1518-23
pubmed: 19164519
J Immunol. 1995 Feb 1;154(3):1470-80
pubmed: 7529804
Nat Med. 2010 Jun;16(6):701-7
pubmed: 20512127
Science. 2002 Sep 20;297(5589):2066-70
pubmed: 12242446
J Neuroimmunol. 2013 Mar 15;256(1-2):55-61
pubmed: 23305745
Nat Med. 2012 Jun 06;18(6):871-82
pubmed: 22674006
Immunity. 2013 Oct 17;39(4):770-81
pubmed: 24138884
Sci Rep. 2017 Nov 27;7(1):16428
pubmed: 29180749
Nat Med. 2019 Jan;25(1):75-81
pubmed: 30478422
Nat Commun. 2016 Feb 26;7:10875
pubmed: 26915335
J Exp Med. 2004 Jun 7;199(11):1577-84
pubmed: 15173206
Immunol Rev. 2019 Mar;288(1):85-96
pubmed: 30874350
Nature. 2005 May 26;435(7041):452-8
pubmed: 15917799
Front Immunol. 2018 May 29;9:1097
pubmed: 29896193
J Exp Med. 2011 Jul 4;208(7):1377-88
pubmed: 21708925
J Leukoc Biol. 2001 Oct;70(4):578-84
pubmed: 11590194
Arthritis Rheumatol. 2015 Apr;67(4):988-99
pubmed: 25581113
Nat Immunol. 2009 Apr;10(4):385-93
pubmed: 19252490
Autoimmunity. 2010 Dec;43(8):607-18
pubmed: 20370572
J Immunol. 2010 Jul 1;185(1):313-26
pubmed: 20519643
J Immunol. 2018 Sep 1;201(5):1359-1372
pubmed: 30030323
Immunity. 1995 Oct;3(4):509-19
pubmed: 7584141
Immunity. 2015 Jul 21;43(1):120-31
pubmed: 26187411
J Immunol. 1996 Jul 1;157(1):417-26
pubmed: 8683147
Immunol Cell Biol. 2016 Nov;94(10):918-924
pubmed: 27562062
Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6670-5
pubmed: 10841565
Arthritis Rheum. 2010 Jan;62(1):234-44
pubmed: 20039395
J Exp Med. 2008 Nov 24;205(12):2873-86
pubmed: 18981236
PLoS One. 2015 Dec 08;10(12):e0144654
pubmed: 26646149
Arthritis Rheum. 1979 Nov;22(11):1188-94
pubmed: 315777
J Clin Invest. 2003 Nov;112(10):1506-20
pubmed: 14617752
J Immunol. 2012 Jun 1;188(11):5612-22
pubmed: 22547698
J Immunol. 2005 Jun 1;174(11):6872-8
pubmed: 15905529
Nat Commun. 2018 Oct 22;9(1):4369
pubmed: 30348969
Front Immunol. 2018 Mar 13;9:487
pubmed: 29593732
Arthritis Res Ther. 2012 Nov 23;14(6):R255
pubmed: 23176102
Semin Immunol. 2009 Oct;21(5):293-300
pubmed: 19595612
N Engl J Med. 2003 Oct 16;349(16):1526-33
pubmed: 14561795
PLoS One. 2013;8(3):e57820
pubmed: 23469245
Immunol Rev. 2010 Sep;237(1):72-89
pubmed: 20727030
Immunity. 2007 Nov;27(5):801-10
pubmed: 17997333
J Exp Med. 2018 Jan 2;215(1):337-355
pubmed: 29212666
Proc Soc Exp Biol Med. 1957 Dec;96(3):575-9
pubmed: 13505796
Immunity. 2012 Nov 16;37(5):880-92
pubmed: 23159227
J Immunol. 1997 Oct 1;159(7):3104-8
pubmed: 9317105
Eur J Immunol. 2008 Jul;38(7):1971-8
pubmed: 18521959
Nat Immunol. 2009 Feb;10(2):167-75
pubmed: 19098919
Nat Immunol. 2013 Apr;14(4):372-9
pubmed: 23475182
J Clin Immunol. 2016 May;36 Suppl 1:34-9
pubmed: 26984851
J Immunol. 2013 Nov 1;191(9):4581-8
pubmed: 24078696
J Exp Med. 2014 Oct 20;211(11):2159-68
pubmed: 25267791
J Exp Med. 2003 Mar 17;197(6):711-23
pubmed: 12642603

Auteurs

Abhinav Seth (A)

Department of Internal Medicine, Section of Rheumatology, New Haven, CT, United States.

Joe Craft (J)

Department of Internal Medicine, Section of Rheumatology, New Haven, CT, United States; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, United States. Electronic address: joseph.craft@yale.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH